Wegovy 1ml: what that volume marking on your pen tells you

Why does a Wegovy pen show a 1ml marking at all?

Pre-filled injection pens display volume markings for manufacturing and quality-control purposes, not as a guide to how much liquid you personally inject each week. The Wegovy pen cartridge holds 1.5ml of semaglutide solution. At lower doses in the titration schedule, the pen releases a smaller volume of that solution; at higher doses it releases more. So if you have spotted a 1ml indicator on your pen or in the product information, it reflects a reference point within the cartridge fill, not the volume of your individual weekly injection.

The figure that governs your treatment is always the dose in milligrams. The licensed titration pathway runs from 0.25mg weekly, through 0.5mg, 1.0mg and 1.7mg, to a maintenance dose of 2.4mg, and for eligible patients, up to 7.2mg following the MHRA's approval of a dedicated single-dose 7.2mg pen in April 2026, with full details of that presentation available on the Wegovy 1mh page. Each of those steps involves a specific volume of solution, but patients rarely need to calculate it. The pen is designed to deliver the correct volume automatically when the dose-selection dial is set. A more detailed look at how each strength is presented can be found on the Wegovy volume and dose guide.

The NHS medicines information for semaglutide explains how the injection works and what to expect at each stage of treatment, it is worth reading alongside the patient information leaflet supplied with your pen. You can find it on the NHS semaglutide medicines page.

Does the 1ml volume figure affect how I use the pen?

In short: no. Wegovy pens are single-patient, auto-dose devices. You do not draw up, measure or calculate the volume yourself. The prescriber sets the dose in milligrams; the pen handles the rest. What matters for correct technique is confirming the right pen strength before injecting, rotating your injection site (abdomen, thigh and upper arm are all suitable), and following the timing in your patient information leaflet.

One practical note: if you are mid-titration and your next dose happens to fall over a bank holiday or you are ordering around a busy period (say, the end of the month when schedules shift) it is worth planning a week ahead. Prescription medicines cannot be dispensed without an up-to-date clinical review, so leaving the repeat order until the pen runs out risks a gap in treatment.

Questions about technique, missed doses or what to do if a pen looks damaged should go to your prescribing team or the patient information leaflet, not to the volume marking. If you are curious about how semaglutide works at the receptor level, the semaglutide overview covers the mechanism in plain language.

Is the 1ml Wegovy volume relevant to any specific pen strength?

The term "1ml Wegovy" sometimes appears in searches when people are trying to identify a particular pen or compare presentations. No licensed Wegovy pen strength is labelled or sold as a "1ml dose" product in the UK. The strengths are defined by milligrams of semaglutide (0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg, and now 7.2mg) and each comes in its own colour-coded pen to reduce selection errors.

The 1.0mg strength is sometimes the source of this confusion. It sits mid-way through the titration ladder and is often the dose at which patients feel the treatment beginning to take effect. But 1.0mg means one milligram of semaglutide, not one millilitre of fluid. Related queries about specific volumes are explored on the 1ml semaglutide page and the 1ml Wegovy reference page.

If you are considering starting Wegovy or are partway through titration and unsure about your current pen, the most reliable source of information about your specific prescription is your prescribing clinician. Our frequently asked questions also cover common pen and dose queries in detail.

What should I actually focus on when using a Wegovy pen?

Forget the millilitre figure. The things that consistently make a difference to how well treatment goes are: injecting on the same day each week, storing pens in the fridge (2–8°C) until use, letting the pen reach room temperature before injecting, and rotating sites to avoid skin reactions. Diet and activity choices alongside the medicine matter too, the guide on getting the most from Wegovy pulls together practical advice from our clinical team on all of those.

Side effects during titration are common, mostly gastrointestinal, nausea, loose stools and reduced appetite are the ones patients most often mention. They tend to settle as the body adjusts, particularly if you eat smaller portions and stay well hydrated. Severe, persistent abdominal pain that spreads to the back is different: that warrants urgent medical attention. The MHRA's Yellow Card scheme is there for reporting any suspected side effects from any medicine.

If you have not yet started treatment and want to understand what is involved (the clinical assessment, the prescription process, the titration plan) our prescribers are available to talk it through. Speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.